Clinical research of cholesterol management for the people with high⁃risk atherosclerotic cardiovascular disease
CSTR:
Author:
Affiliation:

Clc Number:

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Control of cholesterol levels can reduces the incidence of atherosclerotic cardiovascular disease(ASCVD). Increased low-density lipoprotein cholesrerol has been an independent risk factor of ASCVD. Statins,cholesrerol absorption inhibitor,bile acid sequestrant have been proved effectively for reduction of low-density lipoprotein cholesterol. New type therapeutic drugs proprotein convertase subtilisin/kexin type 9 inhibitors,microsomal triglyceride transfer protein inhibitor,antisense oligonucleotide inhibitors,peroxisome proliferator-activated receptor-α have also achieved clinical benefit in recent clinical trials. In this article,we will review the efficacy and safty of cholesterol-lowering drugs,so that we can find out the most effective plan of cholesterol management.

    Reference
    Related
    Cited by
Get Citation

孙 冰,王海昌.动脉粥样硬化性心血管疾病高危人群胆固醇管理的临床研究进展[J].南京医科大学学报(自然科学版英文版),2021,(10):1546-1551.

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:June 10,2021
  • Revised:
  • Adopted:
  • Online: November 05,2021
  • Published:
Article QR Code